FGP
DVAX

Freestone Grove Partners’s Dynavax Technologies DVAX Stock Holding History

Freestone Grove Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-197,747
Closed -$1.96M – 782
2025
Q3 		$1.96M Buy
197,747
+160,291
+428% +$1.67M 0.01% 371
2025
Q2 		$372K Sell
37,456
-12,042
-24% -$127K ﹤0.01% 568
2025
Q1 		$642K Buy
+49,498
New +$655K 0.01% 386

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Freestone Grove Partners's DVAX Position: Q4 2025 in Review

Freestone Grove Partners sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 197,747 shares — an estimated $1.96M sold.

Freestone Grove Partners first reported a position in DVAX in Q1 2025 and held it in 3 quarters. The position peaked at $1.96M in Q3 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Freestone Grove Partners reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 197,747 Dynavax Technologies shares in Q4 2025, an estimated $1.96M.
  • Freestone Grove Partners first reported a position in Dynavax Technologies in Q1 2025 and held it in 3 quarters.
  • Freestone Grove Partners's Dynavax Technologies position peaked at $1.96M in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.